Preblud S R, Bregman D J, Vernon L L
Pediatr Infect Dis. 1985 Sep-Oct;4(5):503-7. doi: 10.1097/00006454-198509000-00013.
Onset of maternal varicella up to 5 days before delivery is associated with in utero exposure to varicella and may result in severe infection in the newborn 5 to 10 days after delivery. Since up to 31% of these newborns may die, routine administration of varicella-zoster immunoglobulin to these infants is recommended. Little is known, however, about the risk of death in other infants with postnatal infection. Available epidemiologic data indicate an estimated death/case ratio for children less than 1 year of age 4 times that for 1- to 14-year-olds (8 in 100,000 vs. 2 in 100,000). Since the actual ages for the infant deaths were lacking, it has been impossible to know how many deaths were possibly related to maternal varicella contracted within the 5 days before delivery. Using National Center for Health Statistics data, we analyzed 92 deaths due to varicella in children less than 1 year old reported between 1968 and 1978 (median age, 5.5 months). Only five deaths occurred in newborns (ages 8 hours to 19 days). These data indicate that intrauterine infection accounts for few varicella deaths in infants. Since postnatal infection accounts for the observed increased risk of death in this age group, the need for preventing postnatal varicella in all infants merits further study. However, based on the small number of deaths occurring annually and the low relative risk compared to other high risk groups, routine postexposure administration of varicella-zoster immunoglobulin to all children less than 1 year of age does not seem warranted at this time.
分娩前5天内孕妇感染水痘与胎儿在子宫内接触水痘有关,可能导致新生儿在出生后5至10天发生严重感染。由于这些新生儿中高达31%可能死亡,因此建议对这些婴儿常规给予水痘-带状疱疹免疫球蛋白。然而,对于其他产后感染婴儿的死亡风险知之甚少。现有流行病学数据表明,估计1岁以下儿童的死亡/病例比是1至14岁儿童的4倍(每10万人中分别为8例和2例)。由于缺乏婴儿死亡的实际年龄信息,因此无法知道有多少死亡可能与分娩前5天内孕妇感染水痘有关。利用美国国家卫生统计中心的数据,我们分析了1968年至1978年期间报告的92例1岁以下儿童因水痘死亡的病例(中位年龄为5.5个月)。只有5例死亡发生在新生儿(年龄为8小时至19天)。这些数据表明,子宫内感染导致的婴儿水痘死亡很少。由于产后感染是该年龄组观察到的死亡风险增加的原因,因此预防所有婴儿产后感染水痘的必要性值得进一步研究。然而,基于每年发生的死亡病例数量较少以及与其他高风险组相比相对风险较低,目前似乎没有必要对所有1岁以下儿童在接触水痘后常规给予水痘-带状疱疹免疫球蛋白。